Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▼ −0.1% | ▼ −4.8% | ▼ −4.5% | ▲ +2.5% | ▲ +2.0% | — | — | ▲ +6.9% |
| Peer average | ▲ +0.2% | ▼ −0.2% | ▼ −0.3% | ▲ +10.4% | ▲ +12.8% | ▲ +73.3% | ▲ +50.0% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The Macquarie Focused International Core ETF, trading under the symbol EXUS, is a passively managed investment vehicle designed to offer broad market exposure to large and mid-capitalization companies located outside the United States. Its strategy involves mirroring the performance of the MSCI World ex USA Index. The fund's asset allocation shows a significant weighting towards the finance sector, constituting roughly 26% of its portfolio, with health technology also representing a notable 10%. Geographically, European firms account for the majority of its holdings at 59%, followed by Asia at 22%, and North America at 11%. Prominent investments within the ETF include SAP SE and ASML Holding NV. EXUS has experienced substantial expansion, with its total assets under management reaching $2.93 billion. Over the past year, its share price has appreciated by an impressive 15.64%. This ETF does not distribute dividends and features a highly competitive expense ratio of just 0.15%. Shares for the fund, which was launched on March 6, 2024, are issued by Deutsche Bank AG under their Xtrackers brand.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2025-12-24 | 2025-12-31 | $0.01 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind EXUS.